Nextech Crossover I GP S.a r.l. 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:47 pm Purchase |
2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Nextech Crossover I GP S.a r.l. | 5,285,714 7.500% |
1,000,000 (+23.33%) |
Filing |
| 2023-07-07 4:15 pm Purchase |
2023-06-27 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Nextech Crossover I GP S.a r.l. | 4,285,714 7.900% |
4,285,714 (New Position) |
Filing |